Hodgkin lymphoma remission prolongation: post-ASCT strategies

4 Views
administrator
administrator
07/09/23

Anna Sureda, MD, PhD, Catalan Institute of Oncology, Barcelona, Spain, discusses the prolongation of remission with post-autologous stem cell transplant (post-ASCT) strategies in Hodgkin lymphoma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next